Also, even though Leo mentions the ABSSSI market w
Post# of 72436
Regarding K, I just want to reiterate he made a point to note that it is very unusual for DF to offer to extend the trial. Also, Leo said he needs to wait until his next meeting with the FDA before giving us more K info. I forget if that was for January or just early 2016, but that means we could get a K update soon.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)